Aligos Therapeutics, Inc.
ALGS • NASDAQ
Aligos Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lawrence Blatt, with a market cap of $49.1M.
Market Cap$49.1M
Employees67.0
CEOLawrence Blatt
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Aligos Therapeutics, Inc. FAQ
Common questions about Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $333.3K.
Aligos Therapeutics, Inc. has approximately 67 employees.